IMM 0.78% 31.8¢ immutep limited

Ann: Prima initiates Phase I melanoma study in Australia, page-20

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 15,518 Posts.
    lightbulb Created with Sketch. 43
    2 quite upbeat announcements just in the past month. Sometimes I just don't know what people expect from a company developing cancer treatments. It's a slow process and results don't come out every week.

    We should be getting some interim trial data in the 3rd quarter (next 8 weeks or so).
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.